http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-97298-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bef96a52ca9eaf6230a857ba74af9a1 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-015 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002 |
| filingDate | 1997-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e225b52ce45c839ae8e19fb2c12de09d |
| publicationDate | 1999-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PE-97298-A1 |
| titleOfInvention | COMPOSITION FOR VACCINES |
| abstract | CHARACTERIZED BECAUSE IT INCLUDES A VARIETY OF PLASMODIUM-DERIVED ANTIGENS IN COMBINATION WITH AN ADJUVANT, WHERE: THE ANTIGENS ARE SELECTED FROM (a) A HYBRID PROTEIN, WHICH INCLUDES A TERMINAL-C PORTION OF THE SURFACE PROTEIN (C) FALCIPARUM, FOUR OR MORE TANDEM REPEATERS OF THE IMMUNODOMINANT REGION AND THE ANTIGEN SURFACE OF THE HEPATITIS B VIRUS (HBsAg), (b) THE TRAP OF A CLONED ISOLATED PLASMODIUM FALCIPARUM OF THAILAND (T / 9/96 ) THE PROTEIN 16kD, (d) THE APIC MEMBRANE ANTIGEN-1 (AMA-1) OF P. FALCIPARUM or P. VIVAX, (e) THE PROTEIN CIRCUNESPOROZOITA (CSP) OF P. FALCIPARUM or P. VIVAX, (f) THE MSP-1 OF P. FALCIPARUM or P. VIVAX, (g) OTHER PROTEINS OF THE EXOERITROCITICA STAGE, (h) OPTIONALLY, PROTEINS OF THE BLOOD STAGE; THE ADJUVANT IS AN EMULSION OF THE OIL TYPE IN WATER, INCLUDING: (a) MPL (LIPIDO MONOFOSFORILO) AND (b) QS21 (NON-TOXIC FRACTION PURIFIED BY HPLC OF A SAPONIN OBTAINED FROM THE SOUTH AMERICAN QUILLAJA SAPONARIA TREE) SUCH ADJUVANT HAS STIMULATING CAPACITY OF THE TH1 TYPE CELL RESPONSE. THIS VACCINE CONFERS IMMUNITY AGAINST PLASMODIUM FALCIPARUM AND / OR PLASMODIUM VIVAX, BEING USEFUL IN THE PREVENTION AND TREATMENT OF MALARIA |
| priorityDate | 1996-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.